Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 01 Aug 2018 for Liquidia Technologies Inc. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Arthur M. Pappas: trading record in brief
This profile gathers the share dealings of Arthur M. Pappas across 3 companies, led by CoLucid Pharmaceuticals, Inc., Kezar Life Sciences, Inc. and Liquidia Technologies Inc. Over a trading history stretching from 1 March 2017 to 30 July 2018, the count stands at 7 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 1 August 2018, reports a transaction in Liquidia Technologies Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Arthur M. Pappas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
191,788 sharesCommon Stock, par value $0.001 per shareSEC:0001144204-18-041397:0
97,287 sharesCommon Stock, par value $0.001 per shareSEC:0001144204-18-041397:1
290,924 sharesCommon Stock, par value $0.001 per shareSEC:0001144204-18-035850:0
23,894 sharesCommon Stock, par value $0.001 per shareSEC:0001144204-18-035850:1
1,871,049 shares@ US$46.5093.9% of flowCommon StockSEC:0000911916-17-000086:0
116,317 shares@ US$46.505.8% of flowCommon StockSEC:0000911916-17-000086:1
5,528 shares@ US$46.500.3% of flowCommon StockSEC:0000911916-17-000086:2
7 of 7 declarations
